Aligos

ALGS

ALGS Aligos NASDAQ
Add to watchlist
--
At close :
--
  • Post market
  • Summary
    Financials
    News
    Filings
    Profile
    ALGS Chart
    See on advanced chart >

    About

    Aligos Therapeutics, Inc. was incorporated in the state of Delaware on February 5, 2018. The company is a clinical-stage biopharmaceutical company currently focused on developing novel therapeutics to address unmet medical needs in viral and liver diseases.
    • Highlight
      A clinical stage biopharmaceutical company that developing therapeutics for viral and liver diseases
    • Industry
    • Exchange
      NASDAQ
    • Listing Date
      10/16/2020
    • Established Date
      02/05/2018
    • Full-time Employees
      66
    • Address
      One Corporate Dr. 2nd Floor South San Francisco CA 94080
    • Tel
      1-800-4666059
    • Website
    • Fiscal Year End Date
      12/31
    • Security Type
      Common Stock